搜索临床试验以:LEO 43204 Formulation 2
总计264个结果
-
GlaxoSmithKline完全的
-
University of FloridaGlaxoSmithKline; Food and Drug Administration (FDA)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的III 期肛门癌 AJCC v8 | 肛管鳞状细胞癌 | IIB 期肛门癌 AJCC v8 | IIIA 期肛门癌 AJCC v8 | IIIB 期肛门癌 AJCC v8 | IIIC 期肛门癌 AJCC v8 | I 期肛门癌 AJCC v8 | II 期肛门癌 AJCC v8 | IIA 期肛门癌 AJCC v8美国
-
International AIDS Vaccine InitiativeGlaxoSmithKline完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
GlaxoSmithKline完全的
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
M.D. Anderson Cancer Center主动,不招人复发性子宫内膜癌 | 复发性子宫内膜子宫内膜样腺癌 | III 期子宫体癌 AJCC v8 | IV 期子宫体癌 AJCC v8 | IVA 期子宫体癌 AJCC v8 | IVB 期子宫体癌 AJCC v8 | 难治性子宫内膜癌 | 难治性子宫内膜样腺癌 | IIIA 期子宫体癌 AJCC v8 | IIIB 期子宫体癌 AJCC v8 | IIIC 期子宫体癌 AJCC v8 | IIIC1 期子宫体癌 AJCC v8 | IIIC2 期子宫体癌 AJCC v8美国